EUVIMEDEUVIMED entdecken
Crossref

Incorporation mutational profile might reduce the importance of blast count in prognostication of low‐risk myelodysplastic syndromes

Marta García-Culebras, Patricia Alcalde, Francisco J Márquez-Malaver, Estrella Carrillo, Elena Soria, Concepción Prats iD, Rosario Morales iD, María T Vargas iD, Jose Antonio Pérez-Simón, Jose F Falantes iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Marta García-Culebras und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Sevilla, Spain. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Mutation. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Addition of molecular data to prognostic models has improved risk stratification of myelodysplastic neoplasms (MDS). However, the role of molecular lesions, particularly in the group of low‐risk disease (LR‐MDS), is uncertain. We evaluated a set of 227 patients with LR‐MDS. Overall survival (OS) and probability of leukaemic progression were the main endpoints. RUNX1 was associated with lower OS and SF3B1 with a reduced risk of death (HR: 1.7, 95% CI, 1.1–2.9; p = 0.05; and HR: 0.23, 95% CI 0.1–0.5; p < 0.001; respectively). TP53 and RUNX1 mutations were predictive covariates for the probability of leukaemic progression ( p < 0.001). Blast percentage, neither analysed as categorical (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelodysplastic SyndromesMutationHumansMaleFemaleAgedMiddle AgedPrognosisAged, 80 and overAdultCore Binding Factor Alpha 2 SubunitDisease ProgressionRNA Splicing FactorsPhosphoproteins

Stichwörter der Autor:innen

MDSacute leukaemiabone marrow pathologygenetic analysisprognostic factors

Substanzen

SF3B1 protein, humanCore Binding Factor Alpha 2 SubunitRUNX1 protein, humanRNA Splicing FactorsPhosphoproteins

Autor:innen und Institutionen

  • Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Sevilla, Spain.
  • Universidad de Sevilla, Sevilla, Spain.

ORCID-Profile: Concepción Prats, Rosario Morales, María T Vargas, Jose F Falantes

Zitieren

APA

García-Culebras, M., Alcalde, P., Márquez-Malaver, F. J., Carrillo, E., Soria, E., Prats, C., Morales, R., Vargas, M. T., Pérez-Simón, J. A., & Falantes, J. F. (2024). Incorporation mutational profile might reduce the importance of blast count in prognostication of low‐risk myelodysplastic syndromes. British Journal of Haematology. https://doi.org/10.1111/bjh.19714

Vancouver

García-Culebras M, Alcalde P, Márquez-Malaver FJ, Carrillo E, Soria E, Prats C, et al. Incorporation mutational profile might reduce the importance of blast count in prognostication of low‐risk myelodysplastic syndromes. British Journal of Haematology. 2024. doi:10.1111/bjh.19714

BibTeX
@article{GarcaCulebras2024,
  author = {García-Culebras, Marta and Alcalde, Patricia and Márquez-Malaver, Francisco J and Carrillo, Estrella and Soria, Elena and Prats, Concepción and Morales, Rosario and Vargas, María T and Pérez-Simón, Jose Antonio and Falantes, Jose F},
  title = {Incorporation mutational profile might reduce the importance of blast count in prognostication of low‐risk myelodysplastic syndromes},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19714}
}
Kostenlos starten →